Europe Multimodal Image Fusion Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Preclinical Multimodal Imaging and Clinical Multimodal Imaging), and Application (Hospitals, Diagnostic Centers, and Academic and Research Ins

Europe Multimodal Image Fusion Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Preclinical Multimodal Imaging and Clinical Multimodal Imaging), and Application (Hospitals, Diagnostic Centers, and Academic and Research Institutes)

The multimodal image fusion software market in Europe is expected to grow from US$ 80.19 million in 2021 to US$ 137.80 million by 2028; it is estimated to reach a CAGR of 8.0% from 2021 to 2028. Healthcare spending by the government and private organizations has increased over the years. This high spending enhances the healthcare infrastructure and influences the adoption of various technologically advanced solutions to improve their treatment plans and diagnostic procedures. Along with the investment in the healthcare infrastructure, the government bodies have been assigning funds for enhancing various diagnostics processes, such as magnetic resonance imaging (MRI) and computed tomography (CT) scans. Thus, these initiatives are fueling the growth of the multimodal image fusion software market during the forecast period.

The clinical multimodal imaging segment led the Europe multimodal image fusion software market, based on type, in 2020. Clinical multimodal imaging is used for the diagnosis process. The clinical multimodal imaging segment growth is driven by the rising technological advancements in cardiac imaging. Moreover, multimodal imaging technology integrates several different imaging techniques to establish an accurate diagnosis of the disease. Due to the benefits of multimodal image fusion software, their usage and demand in clinical trial and process have significantly increased. Institutions and hospitals are significantly investing in the deployment of such software solution to effectively diagnose diseases. In neuroscience clinical research, multimodal imaging is being used to gain insight into the functioning and operation of human brain. Additionally, the clinical multimodal imaging is used in the research and diagnosis of other critical diseases such as cancer.

In Europe, a few countries witnessed an increase in the number of COVID-19 cases, and subsequently attracted strict and prolonged lockdown periods or social isolation. However, Western European countries, such as Germany, France, Russia, and the UK, have seen a significant decrease in their growth activities due to robust healthcare systems. To protect their citizens from SARS-CoV-2, governments have made tremendous investments in their healthcare systems with high-tech products, which have simplified and facilitated COVID-19 diagnosis procedures. Through such investments, European countries also focused on innovative and cost-effective solutions for caregiving. According to the European Commission, the rise in COVID-19 cases across the region has no impact on the number of patients with other diseases, such as heart patients, neurological disorder patients, and Alzheimer’s.

The overall Europe multimodal image fusion software market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. The process also serves the purpose of obtaining an overview and forecast of the Europe multimodal image fusion software market with respect to all the market segments. Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data and gain more analytical insights into the topic. The participants typically involved in this process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers—along with external consultants such as valuation experts, research analysts, and key opinion leaders—specializing in the Europe multimodal image fusion software market. Brainlab AG; Bruker Corporation; Carl Zeiss Meditec; FUJIFILM VisualSonics, Inc.; Intrasense SA; Mediso Ltd; MR Solutions Ltd.; and PerkinElmer Inc. are among the key players operating in the market in this region.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe multimodal image fusion software market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe multimodal image fusion software market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the multimodal image fusion software market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution